Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 28, 2026 09:02 ET | Source: Ampersand Capital Partners

Ampersand Closes Oversubscribed Fund at $1.5 Billion Hard Cap

Boston, MA, May 28, 2026 (GLOBE NEWSWIRE) -- Ampersand Capital Partners is pleased to announce the closing of the firm’s latest fund, Ampersand 2026 (“AMP-26”) Limited Partnership, with $1.5 billion...
April 21, 2026 10:13 ET | Source: 4Bio Capital

4BIO Capital portfolio company Ray Therapeutics announces upsized and oversubscribed $125 Million Series B financing for vision restoration treatments

4BIO Capital continues support as founding investor, having backed Ray Therapeutics since seed funding in 2021 through Series A (2023)Proceeds to support two ongoing clinical-stage programs: RTx-015...
March 24, 2026 08:00 ET | Source: Immutrin

Immutrin raises £65 million ($87 million) Series A to develop next generation antibody therapy for ATTR amyloidosis

Oversubscribed financing led by Frazier Life Sciences with participation from F-Prime, Qiming Venture Partners, SR One and founding investors Cambridge Innovation Capital and Cambridge Enterprise...
March 24, 2026 03:00 ET | Source: Immutrin

Immutrin raises £65 million ($87 million) Series A to develop next generation antibody therapy for ATTR amyloidosis

Oversubscribed financing led by Frazier Life Sciences with participation from F-Prime, Qiming Venture Partners, SR One and founding investors Cambridge Innovation Capital and Cambridge Enterprise...
February 09, 2026 09:00 ET | Source: MS Canada

MS Canada Invites Kids, Teachers, and Book Lovers of All Ages to Join the MS Read-a-Thon Adventure this February

Toronto, ON, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Starting today, the annual MS Read-a-Thon officially kicks off across Canada, challenging young readers to spend the next 30 days (February 9 – March...
October 30, 2025 04:30 ET | Source: Oculis Holding AG

Oculis Announces Oversubscribed $110 Million Financing to Accelerate Privosegtor Development

ZUG, Switzerland, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on breakthrough innovations to...
October 28, 2025 07:00 ET | Source: GHO Capital

GHO Capital announces final close of Fund IV with over €2.5bn of capital to continue investing in its strategy of driving better, faster and more accessible healthcare

Fund IV brings total Assets Under Management (AUM) to c. €9 billion, making GHO the largest healthcare specialist private equity firm headquartered in Europe GHO has diversified its investor base...
October 28, 2025 04:00 ET | Source: GHO Capital

GHO Capital announces final close of Fund IV with over €2.5bn of capital to continue investing in its strategy of driving better, faster and more accessible healthcare

Fund IV brings total Assets Under Management (AUM) to c. €9 billion, making GHO the largest healthcare specialist private equity firm headquartered in Europe GHO has diversified its investor base...
October 06, 2025 07:05 ET | Source: 4Bio Capital

4BIO Capital founded Trogenix secures £70 million Series A financing to drive clinical development of potentially curative therapies for aggressive cancers

Trogenix was founded by 4BIO as a spinout from the University of Edinburgh alongside Professor Steve Pollard and Dr Ken Macnamara in 2023Trogenix's breakthrough Odysseus® platform targets cancer cells...
October 06, 2025 02:05 ET | Source: 4Bio Capital

4BIO Capital founded Trogenix secures £70 million Series A financing to drive clinical development of potentially curative therapies for aggressive cancers

Trogenix was founded by 4BIO as a spinout from the University of Edinburgh alongside Professor Steve Pollard and Dr Ken Macnamara in 2023Trogenix's breakthrough Odysseus® platform targets cancer cells...